Abstract Objective To compare target volume and dosimetry between computed tomography (CT)-and magnetic resonance imaging (MRI)-guided three-dimensional (3D) conformal brachytherapy for locally advanced cervical cancer, and to provide evidence for optimization of the image-guided approach and improvement of treatment regimen. Methods Thirteen patients with locally advanced cervical cancer who were treated with radical radiotherapy in our hospital in 2014 were enrolled as subjects. All patients received MRI-guided 3D conformal intracavitary/interstitial brachytherapy. All patients received MRI and CT scans for each brachytherapy fraction, based on which the target volume delineation, intracavitary/interstitial regimen design, and intracavitary-only treatment regimen design were performed. Comparison of data between MRI and CT scans was performed using paired t test. Results The width and volume of the high-risk clinical target volume (HR-CTV) were significantly smaller in the MRI simulation than in the CT simulation ((38.0±9.4) mm vs. (45.1±8.7) mm, P=0.000;(34.2±15.3) cm3vs. (42.9±20.4) cm3, P=0.002), and the width, thickness, and volume of the intermediate-risk clinical target volume (IR-CTV) were also significantly smaller in the MRI simulation than in the CT simulation ((58.8±9.4) mm vs. (65.4±10.3) mm, P=0.000;(34.8±6.3) mm vs. (37.5±6.3) mm, P=0.001;(90.9±28.5) cm3vs. (109.0±36.4) cm3, P=0.000). The D90 values for HR-CTV and IR-CTV were significantly higher in the MRI simulation than in the CT simulation (87.6 Gy vs. 85.8 Gy, P=0.013;67.7 Gy vs. 66.3 Gy, P=0.005), while the average D2 cm3 values for the bladder and rectum were significantly lower in the MRI simulation than in theCT simulation (73.1 Gy vs. 75.5 Gy, P=0.011;61.0 Gy vs. 65.7 Gy, P=0.000). ConclusionsCompared with the MRI simulation, the CT simulation overestimates the width of target volume. MRI has substantial advantages in dosimetry for target volume and normal tissues. The intracavitary/interstitial treatment can make up the reduced dose for the target volume resulting from the CT simulation.
Zhu Yonggang,Zhao Hongfu,Cheng Guanghui et al. A comparative study of CT-and MRI-based three-dimensional conformal brachytherapy for locally advanced cervical cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(4): 408-412.
Zhu Yonggang,Zhao Hongfu,Cheng Guanghui et al. A comparative study of CT-and MRI-based three-dimensional conformal brachytherapy for locally advanced cervical cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(4): 408-412.
[1] Stenstedt K, Hellstrom AC, Fridsten S, et al. Impact of MRI in the management and staging of cancer of the uterine cervix[J]. Acta Oncol,2011,50(3):420-426.DOI:10.3109/0284186X.2010.541932. [2] Dimopoulos JC, Petrow P, Tanderup K, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV):basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy[J]. Radiother Oncol,2012,103(1):113-122.DOI:10.1016/j.radonc.2011.12.024. [3] Haie-Meder C, Potter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I):concepts and terms in 3 d image based 3 d treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV[J]. Radiother Oncol,2005,74(3):235-245. [4] Potter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (Ⅱ):concepts and terms in 3 d image-based treatment planning in cervix cancer brachytherapy-3 d dose volume parameters and aspects of 3 d image-based anatomy, radiation physics, radiobiology[J]. Radiother Oncol,2006,78(1):67-77. [5] Gay HA, Barthold HJ,O′Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy:a Radiation Therapy Oncology Group consensus panel atlas[J].Int J Radiat Oncol Biol Phys,2012,83(3):353-362.DOI:10.1016/j.ijrobp.2012.01.023. [6] Shin KH, Kim TH, Cho JK, et al. CT-guided intracavitary radiotherapy for cervical cancer:comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters[J].Int J Radiat Oncol Biol Phys,2006,64(1):197-204. [7] Hricak H, Gatsonis C, Coakley FV, et al. Early invasive cervical cancer:CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability[J]. Radiology,2007,245(2):491-498. [8] Viswanathan AN, Dimopoulos J, Kirisits C, et al. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy:results of a prospective trial and preliminary guidelines for standardized contours[J]. Int J Radiat Oncol Biol Phys,2007,68(2):491-498. [9] Krishnatry R,Patel FD,Singh P,et al. CT or MRI for image-based brachytherapy in cervical cancer[J].Jpn J Clin Oncol,2012,42(4):309-313.DOI:10.1093/jjco/hys010. [10] Eskander RN, Scanderbeg D, Saenz CC, et al. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring[J]. Int J Gynecol Cancer,2010,20(1):47-53.DOI:10.1111/IGC.0b013e3181c4a627. [11] Hegazy N, Potter R, Kirisits C, et al. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy:impact of information from FIGO stage with or without systematic inclusion of 3 d documentation of clinical gynecological examination[J]. Acta Oncol,2013,52(7):1345-1352.DOI:10.3109/0284186X.2013.813068. [12] Tanderup K, Nielsen SK, Nyvang GB, et al. From point A to the sculpted pear:MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer[J]. Radiother Oncol,2010,94(2):173-180.DOI:10.1016/j.radonc.2010.01.001. [13] Potter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3 d conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer[J]. Radiother Oncol,2011,100(1):116-123.DOI:10.1016/j.radonc.2011.07.012. [14] Dimopoulos JC, Potter R, Lang S, et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy[J]. Radiother Oncol,2009,93(2):311-315.DOI:10.1016/j.radonc.2009.07.001. [15] Beriwal S, Kannan N, Kim H, et al. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach:feasibility and early results[J]. Clin Oncol (R Coll Radiol),2011,23(10):685-690.DOI:10.1016/j.clon.2011.08.007. [16] Nesvacil N, Potter R, Sturdza A, et al. Adaptive image guided brachytherapy for cervical cancer:a combined MRI-/CT-planning technique with MRI only at first fraction[J]. Radiother Oncol,2013,107(1):75-81.DOI:10.1016/j.radonc.2012.09.005. [17] Van Dyk S, Narayan K, Fisher R, et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound[J]. Int J Radiat Oncol Biol Phys,2009,75(1):64-70.DOI:10.1016/j.ijrobp.2008.10.057. [18] Mahantshetty U, Khanna N, Swamidas J,et al. Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix[J]. Radiother Oncol,2012,102(1):130-134.DOI:10.1016/j.radonc.2011.08.001. [19] Schmid MP, P tter R, Brader P, et al. Feasibility of transrectal ultrasonography for assessment of cervical cancer[J]. Strahlenther Onkol,2013,189(2):123-128.DOI:10.1007/s00066-012-0258-1.
2015, Vol. 24 
